Explore insights, news, and background stories from the Greater Zurich Area – one of Europe’s most advanced business and innovation hubs. This is where international companies, tech pioneers, and investors find the latest updates on artificial intelligence, robotics, biotech, fintech, and more. Whether you're looking for real-world expansion cases, startup success stories, or key developments in Switzerland’s business environment, our articles offer firsthand perspectives and strategic guidance.
Skribble enables digital signing in Zug
Zurich/Zug – Residents of Zug are now able to request documents from the town via the eZug app and receive them directly on their cell phones. Legally valid electronic contract signatures are also possible with this. This is based on technology from the electronic signature provider Skribble.
Investors give QUMEA 1.8 million Swiss francs
Solothurn - QUMEA has received start-up financing amounting to 1.8 million Swiss francs from investors. The start-up’s AI sensor technology enables improved service for persons requiring care. A three-dimensional radar detects their position, posture and condition.
Test phase 2 for COVID 19 drugs
Schlieren ZH – The drug candidate ensovibep developed by Molecular Partners has been administered to a first patient with symptomatic COVID-19 disease in a clinical Phase 2 trial. Authorization might still be achieved in 2021.
Futurae raises investment of 5 million francs
Zurich – Futurae Technologies AG has received additional capital of 5 million Swiss francs from new and existing investors. The customer authentication specialist will use this to extend its B2B platform and accelerate international expansion.
Zurich is one of the top start-up hubs
Trento – In 2020, Zurich became more attractive to start-up founders. As recently revealed by the Startup Heatmap Europe Report, which ranks the most popular start-up locations in Europe, Zurich has jumped six places to take 8th position.
Ticino is becoming a biotech hub
A dynamic biotech scene is taking root in the south of the Greater Zurich Area. It acts as a bridge to Italy and has impressive global ties,, which is a core characteristic of biotechnology in Switzerland as a whole.
EMS-Chemie invests in Domat/Ems site
Domat/Ems GR - EMS-Chemie wants to increase capacity at its Domat/Ems location by 70 percent. To do so, it is investing 300 million Swiss francs over the next five years. Expansion started on Wednesday with the ground-breaking ceremony for a new high-rack warehouse.
Technology to test medicinal product efficacy
Schlieren ZH – The biotech company InSphero and PharmaNest have developed a technology that can be used to test the efficacy of medicinal products. It uses artificial intelligence among other things and aims to speed up the search for drugs to counteract non-alcoholic fatty liver disease.
Trust Square enters partnership in Ticino
Zurich/Lugano – The technology center Trust Square is joining forces with the Ticino Blockchain Technologies Association. Together, the partners plan to launch new projects for blockchain companies. Their aim is to connect startups with investors and researchers.
Meet with an expansion expert
Is Greater Zurich on your expansion radar? We support you on every step of your expansion journey - from location evaluation to fact finding visits.
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Location evaluation support to find the ideal base for your business
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space
- And much more, customized to meet your needs.